COR
$334.71
Cencora, Inc.
Recent News
Here's Why You Should Hold Cencora Stock in Your Portfolio for Now
Cencora's strong U.S. growth, MSO strategy, and raised outlook support long-term potential, but competition and customer losses remain key risks.
Cencora CFO announces retirement
James Cleary will step down from the post on June 30, but stay on as an adviser to the company through the end of the year. He’s the second finance chief of a drug distributor to announce their retirement this month.
How Cardinal Health, The IBD Stock Of The Day, Is Navigating The Tricky Macro
Cardinal Health is Friday's IBD Stock Of The Day. Shares are in a buy zone as the medical wholesaler easily navigates macro challenges.
Why Is Avantor (AVTR) Down 13.6% Since Last Earnings Report?
Avantor (AVTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CAH's Pharma Segment Gains 19% in Q2'26: Is the Growth Sustainable?
CAH's Pharmaceutical and Specialty Solutions segment surged in fiscal Q2'26 with 19% revenue growth to $61B, fueled by specialty drugs, GLP-1 demand and generics momentum.